CAS: 1392487-51-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | G-36 REF: IN-DA009YRZCAS: 1392487-51-2 | 99% | To inquire | Mon 02 Dec 24 |
 | G-36 REF: TR-G932038CAS: 1392487-51-2 | - - - | 166.00 €~621.00 € | Tue 10 Dec 24 |
 | G36 REF: TM-T22794CAS: 1392487-51-2 | 99.86% | 40.00 €~1,253.00 € | Tue 21 Jan 25 |
 | G-36 REF: 3D-SFC48751CAS: 1392487-51-2 | Min. 95% | 194.00 €~986.00 € | Mon 27 Jan 25 |
Ref: IN-DA009YRZ
| 5mg | 201.00 € | ||
| 10mg | 338.00 € | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 2 Dec 2024
G-36
Controlled ProductCAS:1392487-51-2
Formula:
C22H22BrNO2
Color and Shape:
Neat
Molecular weight:
412.33
Ref: TR-G932038
| 1mg | 166.00 € | ||
| 5mg | 621.00 € | ||
| 2500µg | 349.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
G36
CAS:1392487-51-2
G36 is a cell-permeable non-steroidal antagonist of GPER.
Formula:
C22H22BrNO2
Purity:
99.86%
Color and Shape:
Solid
Molecular weight:
412.32
Ref: TM-T22794
| 1mg | 40.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 134.00 € | ||
| 25mg | 235.00 € | ||
| 50mg | 397.00 € | ||
| 100mg | 587.00 € | ||
| 500mg | 1,253.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
G-36
CAS:1392487-51-2
G-36 is a drug that has been shown to be effective in the treatment of …
Formula:
C22H22BrNO2
Purity:
Min. 95%
Molecular weight:
412.33 g/mol
Ref: 3D-SFC48751
| 1mg | 194.00 € | ||
| 2mg | 310.00 € | ||
| 5mg | 436.00 € | ||
| 10mg | 647.00 € | ||
| 25mg | 986.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
